Publications

Read Now

December 2020 (Revised April 2021)
Case

IBM Watson at MD Anderson Cancer Center

By: Shane Greenstein, Mel Martin and Sarkis Agaian

After discovering that their cancer diagnostic tool, designed to leverage the cloud computing power of IBM Watson, needed greater integration into the clinical processes at the MD Anderson Cancer Center, the development team had difficult choices to make. The Oncology... View Details

Keywords: Decision Making; Innovation Strategy; Knowledge Management; Knowledge Use and Leverage; Operations; Failure; Information Technology; Applications and Software; Health Care and Treatment; Product Development; Health Industry; Information Technology Industry; Technology Industry; United States; Houston; Texas

Article

The Implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on Cancer Care Delivery

By: Heidi W. Albright, Mark Moreno, Thomas W. Feeley, Ronald Walters, Marc Samuels, Alissa Pereira and Thomas W. Burke

In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. This legislation attempts to address cost control and improve the quality of healthcare in the United States. Cancer is a... View Details

Keywords: Health Care Policy; Health Care; Cancer Care In The U.S.; Cancer Care Services; Health; Law; Quality; Health Industry; North and Central America

Find at Harvard

29 Oct 2010
News

The Mental Game of Breast Cancer

06 Jul 2011
News

Washington's Complacency Cancer

Choose the cancer center that’s right for your cancer

13 Mar 2020
News

Expanding Cancer Care

Lesley Solomon (MBA 2004) is the senior vice president for innovation and chief innovation officer at the Dana-Farber Cancer Institute. In this interview from June 2019, she discusses how she works to ensure that the work of Dana-Farber... View Details

Research Summary

Negotiating in the Shadow of Cancer

By: Deepak Malhotra

I am working with collaborators at the Memorial Sloan Kettering Cancer Center to develop interventions that will help surgeons communicate more effectively with cancer patients, with the goal of helping patients make better decisions regarding their health. View Details

April 2018 (Revised September 2018)
Case

Impact Investing for Cancer

By: Richard G. Hamermesh and Matthew G. Preble

It is early 2018, and Emily Park, managing director of impact for the Abreu Family Office, is meeting the next day with Tomás and Maria Abreu to discuss the various ways in which the Abreus can allocate a planned $100 million to make a meaningful difference in cancer... View Details

Keywords: Impact Investing; Investment; Health Disorders; Philanthropy and Charitable Giving; Decision Choices and Conditions

September 2017
Editorial

Helping Patients with Cancer Navigate Narrow Networks

By: Stephen M. Schleicher, Emeline M. Aviki and Thomas W. Feeley

The Affordable Care Act of 2010 (ACA) was designed primarily to improve patient access to affordable health care. The access-expanding provisions of the ACA included federal- and state-based health insurance exchanges with minimum coverage requirements and preexisting... View Details

Keywords: Health Care and Treatment; Insurance; Problems and Challenges; United States

Find at Harvard

Register to Read

15 Jan 2018
News

A Better Business Model for Fighting Cancer

Keywords: Scientific Research and Development Services

November 2008 (Revised October 2009)
Case

American Cancer Society: Access to Care

By: Robert L. Simons and Kathryn Rosenberg

CEO John Seffrin decides to radically change the strategy of the American Cancer Society. The new Access to Care strategy relies on advocacy to change public policy and increase the number of Americans eligible for cancer prevention and treatment. The new strategy... View Details

Keywords: Values and Beliefs; Governance Controls; Leading Change; Organizational Change and Adaptation; Organizational Structure; Nonprofit Organizations; Business Strategy; Health Industry; United States

18 Apr 2019
News

Open Innovation Contestants Build AI-Based Cancer Tool

Article

Comparative Costs of Advanced Proton and Photon Radiation Therapies: Lessons from Time-driven Activity-based Costing in Head and Neck Cancer

By: Nikhil G. Thaker, Steven J. Frank and Thomas W. Feeley

Time-driven activity-based costing (TDABC) is an innovative costing tool in healthcare that can be used to directly compare the true cost of competing technologies over the full care cycle. Rather than only comparing therapeutic effectiveness over a limited number of... View Details

Keywords: Head And Neck Cancer; IMRT; Proton Therapy; Time-Driven ABC; Information Technology; Activity Based Costing and Management; Medical Specialties

Read Now

26 Feb 2010
News

Cancer Can't Stop Me

Keywords: Health, Social Assistance

01 Apr 2015
Research & Ideas

The Slow, Steady Battle to Fix Cancer Care

After a cancer patient's first 30 days in the American medical system, the bills start stacking up—right next to the pile of paperwork explaining benefits. "It's very hard for patients to match these things up," says Dr. Thomas... View Details

Keywords: by Carmen Nobel; Health

Article

Time-Driven Activity-Based Costing in Breast Cancer Care Delivery

By: Navraj S. Nagra, Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley and Andrea L. Pusic

We used time-driven activity-based costing (TDABC) to calculate the complete cost of breast cancer care—initial treatment planning, chemotherapy, radiation therapy, surgical resection and reconstruction, and ancillary services (psychosocial oncology, physical therapy.... View Details

Keywords: Healthcare; Time-Driven Activity-Based Costing; Health Care and Treatment; Cost

Find at Harvard

August 2007 (Revised November 2008)
Case

Biocon: Launching a New Cancer Drug in India

By: Sunil Gupta and Das Narayandas

Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India. View Details

Keywords: Price; Health Care and Treatment; Marketing Strategy; Product Launch; Planning; Biotechnology Industry; Pharmaceutical Industry; India